Michael L. Kaufman

1.2k citations

21 papers · 527 indexed · h-index 14

Co-authors: Donald B. Kohn Roger P. Hollis Zulema Romero Aaron Cooper Beatriz Campo-Fernández Xiaoyan Wang Caroline Y. Kuo Fabrizia Urbinati
Topics: Virus-based gene therapy research (12 papers)CRISPR and Genetic Engineering (8 papers)RNA Interference and Gene Delivery (6 papers)
Cited by: Business and International Management Genetics
Journals: Blood Development Cancer Research
Partner nations: United States Italy France

In The Last Decade

Michael L. Kaufman

21 papers receiving 525 citations

Peers

Countries citing papers authored by Michael L. Kaufman

Since Specialization

Citations

This map shows the geographic impact of Michael L. Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Kaufman more than expected).

Fields of papers citing papers by Michael L. Kaufman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Kaufman. The network helps show where Michael L. Kaufman may publish in the future.

Co-authorship network of co-authors of Michael L. Kaufman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Kaufman. A scholar is included among the top collaborators of Michael L. Kaufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Kaufman. Michael L. Kaufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In Situ Spatial Reconstruction of Distinct Normal and Pathological Cell Populations Within the Human Adrenal Gland 2023 ·Journal of the Endocrine Society ·Rui Fu,(unknown),Michael L. Kaufman,(unknown),(unknown),Michael R. Clay,(unknown),Katja Kiseljak‐Vassiliades,Lauren Fishbein,Neelanjan Mukherjee	2
2	Binge ethanol exposure in advanced age elevates neuroinflammation and early indicators of neurodegeneration and cognitive impairment in female mice 2023 ·Brain Behavior and Immunity ·Paige Anton,(unknown),Michael L. Kaufman,Nicolas Busquet,Elizabeth J. Kovacs,Rebecca L. McCullough	13
3	An enhancer located in a Pde6c intron drives transient expression in the cone photoreceptors of developing mouse and human retinas 2022 ·Developmental Biology ·Vismaya S. Bachu,Sangeetha Kandoi,(unknown),Michael L. Kaufman,(unknown),Deepak A. Lamba,Joseph A. Brzezinski	3
4	Gene delivery using AAV8 in vivo for disease stabilization in a bimodal gene therapy approach for the treatment of ADA-deficient SCID 2021 ·Molecular Therapy — Methods & Clinical Development ·Denise A. Carbonaro-Sarracino,(unknown),(unknown),Michael L. Kaufman,(unknown),Xiaoyan Wang,Donald B. Kohn	1
5	Initiation of Otx2 expression in the developing mouse retina requires a unique enhancer and either Ascl1 or Neurog2 activity 2021 ·Development ·Michael L. Kaufman,Noah Goodson,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Kenneth L. Jones,Joseph A. Brzezinski	17
6	Dosing and Re-Administration of Lentiviral Vector for In Vivo Gene Therapy in Rhesus Monkeys and ADA-Deficient Mice 2019 ·Molecular Therapy — Methods & Clinical Development ·Denise A. Carbonaro-Sarracino,Alice F. Tarantal,C. Chang I. Lee,Michael L. Kaufman,Stephen Wandro,(unknown),(unknown),(unknown),(unknown),(unknown),Cinnamon L Hardee,Xiaoyan Wang,Donald B. Kohn	15
7	Transcriptional profiling of murine retinas undergoing semi-synchronous cone photoreceptor differentiation 2019 ·Developmental Biology ·Michael L. Kaufman,(unknown),Noah Goodson,Shereen Chew,(unknown),Kenneth L. Jones,Deepak A. Lamba,Joseph A. Brzezinski	17
8	Gene Therapy for Sickle Cell Disease : A Lentiviral Vector Comparison Study 2018 ·Human Gene Therapy ·Fabrizia Urbinati,(unknown),Katelyn E. Masiuk,Valentina Poletti,Roger P. Hollis,(unknown),Michael L. Kaufman,Devin Brown,Fulvio Mavilio,Donald B. Kohn	27
9	Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome 2018 ·Cell Reports ·Caroline Y. Kuo,Joseph Long,Beatriz Campo-Fernández,Satiro De Oliveira,Aaron Cooper,Zulema Romero,Megan D. Hoban,Alok V. Joglekar,Georgia R. Lill,Michael L. Kaufman,Sorel Fitz‐Gibbon,Xiaoyan Wang,Roger P. Hollis,Donald B. Kohn	105
10	Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA Repair 2018 ·Stem Cells ·Anastasia Lomova,(unknown),Beatriz Campo-Fernández,Carmen Flores,Michael L. Kaufman,Sorel Fitz‐Gibbon,Xiaoyan Wang,(unknown),Devin Brown,Mark A. DeWitt,Jacob E. Corn,Roger P. Hollis,Zulema Romero,Donald B. Kohn	68
11	Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor Cells 2017 ·Molecular Therapy ·Joseph Long,Megan D. Hoban,Aaron Cooper,Michael L. Kaufman,Caroline Y. Kuo,Beatriz Campo-Fernández,Dianne Lumaquin,Roger P. Hollis,(unknown),Donald B. Kohn,Zulema Romero	23
12	Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease 2017 ·Cytotherapy ·Fabrizia Urbinati,(unknown),Sabine Geiger,Beatriz Campo Fernandez,Michael L. Kaufman,Aaron Cooper,Zulema Romero,Filippo Marchioni,Lilith Reeves,Elizabeth J. Read,Barbara Nowicki,Elke Grassman,(unknown),Xiaoyan Wang,Roger P. Hollis,Donald B. Kohn	16
13	Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted Endonucleases 2016 ·Molecular Therapy — Nucleic Acids ·Carmen Flores,(unknown),John W. Phillips,Caroline Y. Kuo,Stephen Y. Lai,Georgia R. Lill,Aaron Cooper,Michael L. Kaufman,Fabrizia Urbinati,Xiaoyan Wang,Roger P. Hollis,Donald B. Kohn	50
14	The human ankyrin 1 promoter insulator sustains gene expression in a β-globin lentiviral vector in hematopoietic stem cells 2015 ·Molecular Therapy — Methods & Clinical Development ·Zulema Romero,Beatriz Campo-Fernández,(unknown),Michael L. Kaufman,Fabrizia Urbinati,Aaron Cooper,Megan D. Hoban,(unknown),Dianne Lumaquin,Xiaoyan Wang,Shantha Senadheera,Roger P. Hollis,Donald B. Kohn	12
15	Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells 2015 ·Experimental Hematology ·Fabrizia Urbinati,Phillip W. Hargrove,Sabine Geiger,Zulema Romero,(unknown),Michael L. Kaufman,Roger P. Hollis,Christopher B. Chambers,Derek A. Persons,Donald B. Kohn,Andrew Wilber	27
16	Enrichment of Human Hematopoietic Stem/Progenitor Cells Facilitates Transduction for Stem Cell Gene Therapy 2015 ·Stem Cells ·(unknown),Fabrizia Urbinati,Zulema Romero,Beatriz Campo-Fernández,Michael L. Kaufman,Aaron Cooper,Katelyn E. Masiuk,Roger P. Hollis,Donald B. Kohn	25
17	HSV-sr39TK Positron Emission Tomography and Suicide Gene Elimination of Human Hematopoietic Stem Cells and Their Progeny in Humanized Mice 2014 ·Cancer Research ·Eric H. Gschweng,Melissa McCracken,Michael L. Kaufman,Michelle Ho,Roger P. Hollis,Xiaoyan Wang,(unknown),Richard C. Koya,Thinle Chodon,Antoni Ribas,Owen N. Witte,Donald B. Kohn	26
18	Allelic Exclusion and Peripheral Reconstitution by TCR Transgenic T Cells Arising From Transduced Human Hematopoietic Stem/Progenitor Cells 2013 ·Molecular Therapy ·Francesca Giannoni,Cinnamon L Hardee,(unknown),Eric H. Gschweng,Shantha Senadheera,Michael L. Kaufman,(unknown),Ingrid Bahner,Vivian H. Gersuk,Xiaoyan Wang,David W. Gjertson,David Baltimore,Owen N. Witte,James S. Economou,Antoni Ribas,Donald B. Kohn	48
19	Zinc Finger Nucleases Targeting The β-Globin Locus Drive Efficient Correction Of The Sickle Mutation In CD34+ Cells 2013 ·Blood ·Megan D. Hoban,Alok V. Joglekar,David Gray,Michael L. Kaufman,Fabrizia Urbinati,Shantha Senadheera,Gregory J. Cost,Andreas Reik,Michael C. Holmes,Philip D. Gregory,Roger P. Hollis,Donald B. Kohn	2
20	Gene therapy/bone marrow transplantation in ADA-deficient mice: roles of enzyme-replacement therapy and cytoreduction 2012 ·Blood ·Denise A. Carbonaro,(unknown),Xingchao Wang,Xiaojin Yu,Nora Rozengurt,Michael L. Kaufman,Xiaoyan Wang,David W. Gjertson,Yang Zhou,Michael R. Blackburn,Donald B. Kohn	27

About Michael L. Kaufman

Michael L. Kaufman is a scholar working on Genetics, Genetics and Biological Psychiatry, having authored 21 papers that have together received 527 indexed citations. Recurring topics across this work include Virus-based gene therapy research (12 papers), CRISPR and Genetic Engineering (8 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Business and International Management (19 citations), Genetics (99 citations) and Genetics (237 citations). Michael L. Kaufman has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Donald B. Kohn, Roger P. Hollis, Zulema Romero, Aaron Cooper, Beatriz Campo-Fernández, Xiaoyan Wang, Caroline Y. Kuo, Fabrizia Urbinati, Sorel Fitz‐Gibbon and Georgia R. Lill. Their work appears in journals such as Blood, Development and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact